Literature DB >> 17766716

High phenotypic intrafamilial variability in patients with Pendred syndrome and a novel duplication in the SLC26A4 gene: clinical characterization and functional studies of the mutated SLC26A4 protein.

Laura Fugazzola1, Valentina Cirello, Silvia Dossena, Simona Rodighiero, Marina Muzza, Pierangela Castorina, Faustina Lalatta, Umberto Ambrosetti, Paolo Beck-Peccoz, Guido Bottà, Markus Paulmichl.   

Abstract

OBJECTIVE: Pendred syndrome (PS) is characterized by the association of sensorineural hearing loss (SNHL) and a partial iodide organification defect at the thyroid level. It is caused by mutations in the SLC26A4 gene. The encoded transmembrane protein, called pendrin, has been found to be able to transport chloride and other anions.
DESIGN: The aim of the present study was to characterize a family with PS, which shows a strong intrafamilial phenotypic variability, including kidney atrophy in one member. The age of disease-onset was significantly different in all three affected siblings, ranging from 2 to 21 years for thyroid alterations and from 1.5 to 11 years for SNHL.
METHODS: Clinical and genetic studies were carried out in affected siblings. The functional activity of the novel duplication found was studied by a fluorimetric method in a human renal cell line (HEK293 Phoenix) in which the protein was overexpressed.
RESULTS: All three siblings were found to be compound heterozygotes for the missense mutation (1226G>A, R409H) and for a novel 11 bp duplication (1561_1571CTTGGAATGGC, S523fsX548). The latter mutation creates a frame shift leading to the loss of the entire carboxy-terminus domain. Functional studies of this mutant demonstrated impaired transport of chloride and iodide when expressed in HEK 293 Phoenix cells, when compared with wild type pendrin.
CONCLUSIONS: A novel 11 bp duplication was found in a family with Pendred syndrome, showing a high intrafamilial phenotypic variability. An impaired transmembrane anionic transport of the mutated SLC26A4 protein was demonstrated in functional studies using a heterologous cell system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766716     DOI: 10.1530/EJE-07-0263

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  11 in total

1.  Reduction of Cellular Expression Levels Is a Common Feature of Functionally Affected Pendrin (SLC26A4) Protein Variants.

Authors:  Vanessa C S de Moraes; Emanuele Bernardinelli; Nathalia Zocal; Jhonathan A Fernandez; Charity Nofziger; Arthur M Castilho; Edi L Sartorato; Markus Paulmichl; Silvia Dossena
Journal:  Mol Med       Date:  2016-01-04       Impact factor: 6.354

2.  Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation.

Authors:  Amiel A Dror; Yael Politi; Hashem Shahin; Danielle R Lenz; Silvia Dossena; Charity Nofziger; Helmut Fuchs; Martin Hrabé de Angelis; Markus Paulmichl; Steve Weiner; Karen B Avraham
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

3.  Functional characterization of pendrin mutations found in the Israeli and Palestinian populations.

Authors:  Silvia Dossena; Charity Nofziger; Zippora Brownstein; Moien Kanaan; Karen B Avraham; Markus Paulmichl
Journal:  Cell Physiol Biochem       Date:  2011-11-18

Review 4.  Integration of human and mouse genetics reveals pendrin function in hearing and deafness.

Authors:  Amiel A Dror; Zippora Brownstein; Karen B Avraham
Journal:  Cell Physiol Biochem       Date:  2011-11-18

5.  Identification of allelic variants of pendrin (SLC26A4) with loss and gain of function.

Authors:  Silvia Dossena; Aigerim Bizhanova; Charity Nofziger; Emanuele Bernardinelli; Josef Ramsauer; Peter Kopp; Markus Paulmichl
Journal:  Cell Physiol Biochem       Date:  2011-11-18

6.  Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.

Authors:  Andrea M Oza; Marina T DiStefano; Sarah E Hemphill; Brandon J Cushman; Andrew R Grant; Rebecca K Siegert; Jun Shen; Alex Chapin; Nicole J Boczek; Lisa A Schimmenti; Jaclyn B Murry; Linda Hasadsri; Kiyomitsu Nara; Margaret Kenna; Kevin T Booth; Hela Azaiez; Andrew Griffith; Karen B Avraham; Hannie Kremer; Heidi L Rehm; Sami S Amr; Ahmad N Abou Tayoun
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

7.  Absence of primary hypothyroidism and goiter in Slc26a4 (-/-) mice fed on a low iodine diet.

Authors:  D Calebiro; P Porazzi; M Bonomi; S Lisi; A Grindati; D De Nittis; L Fugazzola; M Marinò; G Bottà; L Persani
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

8.  Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA.

Authors:  Alejandra Pera; Silvia Dossena; Simona Rodighiero; Marta Gandía; Guido Bottà; Giuliano Meyer; Felipe Moreno; Charity Nofziger; Concepción Hernández-Chico; Markus Paulmichl
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

9.  Functional Testing of SLC26A4 Variants-Clinical and Molecular Analysis of a Cohort with Enlarged Vestibular Aqueduct from Austria.

Authors:  Sebastian Roesch; Emanuele Bernardinelli; Charity Nofziger; Miklós Tóth; Wolfgang Patsch; Gerd Rasp; Markus Paulmichl; Silvia Dossena
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

10.  Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels.

Authors:  Dona M Kanavy; Shannon M McNulty; Meera K Jairath; Sarah E Brnich; Chris Bizon; Bradford C Powell; Jonathan S Berg
Journal:  Genome Med       Date:  2019-11-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.